Loss of inhibitory synapses on the soma and axon initial segment of pyramidal cells in human epileptic peritumoural neocortex: Implications for epilepsy

Brain Research Bulletin

Volumn 44, Issue 1, 1997, Pages 47-66

  Marco, Pilar ^a   Sola, Rafael G ^b   Cajal, Santiago Ramón Y ^c   DeFelipe, Javier ^a  

^a INSTITUTO CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Brain tumours; Epilepsy; Gliosis; Interneurone; Pyramidal cells; Synapses

Indexed keywords

4 AMINOBUTYRIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DECARBOXYLASE; HLA DR ANTIGEN; NEUROFILAMENT PROTEIN; PARVALBUMIN;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOARCHITECTURE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTERNEURON; NEOCORTEX; NERVE CELL EXCITABILITY; NERVE FIBER; PERIKARYON; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SEIZURE; SYNAPTIC INHIBITION; TEMPORAL LOBE EPILEPSY; TUMOR GROWTH;

ADULT; ASTROCYTOMA; AXONS; CEREBRAL CORTEX; EPILEPSY, TEMPORAL LOBE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MICROSCOPY, ELECTRON; PYRAMIDAL CELLS; SYNAPSES;

EID: 0030805311     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(97)00090-7     Document Type: Article

References (46)

1. Banati R. B., Gehrmann J., Schubert P., Kreutzberg G. W. Cytotoxicity of microglia. Glia. 7:1993;111-118.
2. Berger M. S., Ghatan S., Haglund M. M., Dobbins J., Ojemann G. A. Low-grade gliomas associated with intractable epilepsy: Seizure outcome utilizing electrocorticography during tumor resection. J. Neurosurg. 79:1993;62-69.
3. Blinzinger K., Kreutzberg G. Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Z. Zellforsch. Mikrosk. Anat. 85:1968;145-157.
4. Campbell M. J., Morrison J. H. Monoclonal antibody to neurofilament protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey neocortex. J. Comp. Neurol. 282:1989;191-205.
5. Carpenter A. F., Carpenter P. W., Markesbery W. R. Morphometric analysis of microglia in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 5:1993;601-608.
6. Celio M. R., Baier W., Schärer L., De Viragh P. A., Gerday C. Monoclonal antibodies directed against the calcium binding protein parvalbumin. Cell Calcium. 9:1988;81-86.
7. Colonnier M. The electron-microscopic analysis of the neuronal organization of the cerebral cortex. Schmitt F. O., Worden F. G., Adelman G., Dennis S. G. The organization of the cerebral cortex. 1981;125-152 MIT Press, Cambridge.
8. DeFelipe J. Neocortical neuronal diversity: Chemical heterogeneity revealed by co-localization studies of classic neurotransmitters, neuropeptides, calcium binding proteins and cell surface molecules. Cereb. Cortex. 3:1993;273-289.
9. DeFelipe J., Fairén A. A type of basket cell in superficial layers of the cat visual cortex: A Golgi-electron microscope study. Brain Res. 244:1982;9-16.
10. DeFelipe J., Fariñas I. The pyramidal neuron of the cerebral cortex: Morphological and chemical characteristics of the synaptic inputs. Prog. Neurobiol. 39:1992;563-607.
11. DeFelipe J., Fairén A. A simple and reliable method for correlative light and electron microscopic studies. J. Histochem. Cytochem. 41:1993;769-772.
12. DeFelipe J., Sola R. G., Marco P. Changes in excitatory and inhibitory synaptic circuits in the human epileptogenic neocortex. Conti F., Hicks T. P. Excitatory amino acids and the cerebral cortex. 1996;299-312 MIT Press, Cambridge, MA.
13. del Río M. R., DeFelipe J. A study of SMI 32-stained pyramidal cells, parvalbumin-immunoreactive chandelier cells and presumptive thalamocortical axons in the human temporal neocortex. J. Comp. Neurol. 342:1994;389-408.
14. del Río M. R., DeFelipe J. Colocalization of calbindin D28k, calretinin and GABA immunoreactivities in neurons of the human temporal cortex. J. Comp. Neurol. 369:1996;472-482.
15. Ferrer I., Soriano E., Tuñón T., Fonseca M., Guionnet N. Parvalbumin immunoreactive neurons in normal human temporal neocortex and in patients with Alzheimer's disease. J. Neurol. Sci. 106:1991;135-141.
16. Ferrer I., Oliver B., Russi A., Casas R., Rivera R. Parvalbumin and calbindin-D28k immunocytochemistry in human neocortical epileptic foci. J. Neurol. Sci. 123:1994;18-25.
17. Freund T. F., Maglóczky Z. S., Soltész I., Somogyi P. Synaptic connections, axonal and dendritic patterns of neurons immunoreactive for cholecystokinin in the visual cortex of the cat. Neuroscience. 19:1986;1133-1359.
18. Fried I., Kim J. H., Spencer D. D. Limbic and neocortical gliomas associated with intractable seizures: A distinct clinicopathological group. Neurosurgery. 34:1994;815-824.
19. Gallyas F. Silver staining of myelin by means of physical development. Neurol. Res. 1:1979;203-209.
20. García-Segura L. M., Luquiín S., Párducz A., Naftolin A. Gonadal hormone regulation of glial fibrillary acidic protein immunoreactivity and glial ultrastructure inthe rat neuroendrocrine hypothalamus. Glia. 10:1994;59-69.
21. Graeber M. B., Kreutzberg G. W. Delayed astrocyte reaction following facial nerve axotomy. J. Neurocytol. 17:1988;209-220.
22. Gray E. G., Guillery R. W. Synaptic morphology in the normal and degenerating nervous system. Int. Rev. Cytol. 19:1966;111-182.
23. Haglund M. M., Berger M. S., Kunkel D. D., Franck J. E., Ghatan S., Ojemann G. A. Changes in gamma-aminobutyric acid and somatostatin in epileptic cortex associated with low-grade gliomas. J. Neurosurg. 77:1992;209-216.
24. Hayes T. L., Lewis D. A. Nonphosphorylated neurofilament protein and calbindin immunoreactivity in layer III pyramidal neurons of human neocortex. Cereb. Cortex. 2:1992;56-67.
25. Hof P. R., Cox K., Morrison J. H. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. J. Comp. Neurol. 301:1990;44-54.
26. Hof P. R., Cox K., Young W. G., Celio M. R., Rogers J., Morrison J. H. Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 50:1991;451-462.
27. Jones E. G. GABAergic neurons and their role in cortical plasticity in primates. Cereb. Cortex. 3:1993;361-372.
28. Kaufman D. L., Houser C. R., Tobin A. J. Two forms of the γ -aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J. Neurochem. 56:1991;720-723.
29. Ketz E. Brain tumors and epilepsy. Vinken P. J., Bruyn G. W. Handbook of clinical neurology. 16:1974;254-269 North-Holland, Amsterdam.
30. Kisvárday Z. F., Martin K. A. C., Whitteridge D., Somogyi P. Synaptic connections of intracellularly filled clutch cells: A type of small basket cell in the visual cortex of the cat. J. Comp. Neurol. 241:1985;111-137.
31. Lee V. M.-Y., Otvos L. Jr., Carden M. J., Hollosi M., Dietzschold B., Lazzarini R. A. Identification of the major multiphosphorylation site in mammalian neurofilaments. Proc. Natl. Acad. Sci. USA. 85:1988;1998-2002.
32. Marco, P.; DeFelipe, J. Altered synaptic circuitry in the human temporal neocortex removed from epileptic patients. Exp. Brain Res. 114:1-10.
33. Marco P., Sola R. G., Pulido P., Alijarde M. T., Sánchez A., Ramón y Cajal S., DeFelipe J. Inhibitory neurons in the human epileptogenic temporal neocortex: An immunocytochemical study. Brain. 119:1996;1327-1348.
34. Mesulam M., Geula C. Differential distribution of a neurofilament protein epitope in acetylcholinesterase-rich neurons of human cerebral cortex. Brain Res. 544:1991;169-173.
35. Morrison J. H., Lewis D. A., Campbell M. J., Huntley G. W., Benson D. L., Bouras C. A monoclonal antibody to nonphosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease. Brain Res. 416:1987;331-336.
36. Peters A. Synaptic specificity in the cerebral cortex. Edelman G. M., Gall W. E., Cowan W. M. Synaptic fuction. 1987;373-397 John Wiley, New York.
37. Peters A., Palay S. L., Webster H., de F. The fine structure of the nervous system. Neurons and their supporting cells. 3rd ed. 1991;Oxford University Press, New York.
38. Pilcher W. H., Silbergeld D. L., Berger M. S., Ojemann G. A. Intraoperative electrocorticography during tumor resection: Impact on seizure outcome in patients with gangliogliomas. J. Neurosurg. 78:1993;891-902.
39. Russell D. S., Rubinstein L. J. Pathology of tumours of the nervous system. 5th ed. 1989;Edward Arnold, London.
40. Ribak C. E. Axon terminals of GABAergic chandelier cells are lost at epileptic foci. Brain Res. 326:1985;251-260.
41. Schiffer D., Giordana M. T., Soffietti R., Sciolla R. Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy. Acta Neuropathol. 58:1982;291-299.
42. Smith D. F., Hutton J. L., Sandermann D., Foy P. M., Shaw M. D. M., Williams I. R., Chadwick D. W. The prognosis of primary intracerebral tumors presenting with epilepsy: The outcome of medical and surgical management. J. Neurol. Neurosurg. Psychiatry. 54:1991;915-920.
43. Somogyi P., Kisvárday Z. F., Martin K. A. C., Whitteridge D. Synaptic connections of morphologically identified and physiologically characterized large basket cells in the striate cortex of cat. Neuroscience. 10:1983;261-294.
44. Sternberger L. A., Sternberger N. H. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc. Natl. Acad. Sci. USA. 80:1983;6126-6130.
45. Winger M. J., Macdonald D. R., Cairncross J. G. Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J. Neurosurg. 71:1989;487-493.
46. Zentner J., Hufnagel A., Wolf H. K., Ostertun B., Behrens E., Campos M. G., Solymosi L., Elger C. E., Wiestler O. D. Surgical treatment of temporal lobe epilepsy: Clinical, radiological, and histopathological findings in 178 patients. J. Neurol. Neurosurg. Psychiatry. 58:1995;666-673.